Results 61 to 70 of about 1,640,336 (314)

Status of barium studies in the present era of oncology: Are they a history?

Indian Journal of Medical and Paediatric Oncology, 2016
With the advent of the modern imaging technologies, the present era of oncology is seeing steady decline in requests for barium studies due to the many reasons. It is prudent to mention here, that, barium examinations cannot be made obsolete!
Abhishek Mahajan, Subash Desai, Nilesh Pandurang Sable, Meenakshi Haresh Thakur   +3 more
doaj   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Evaluating Rivaroxaban for Thromboprophylaxis in Cancer Patients with Long-Term Venous Access Devices: A Retrospective Cohort Study

Vascular Health and Risk Management
Bin Jia,1,* Hui Lv,2,* Ting Gong,2 Xin Wang,2 Qing Ma,2 Yaoyao Ren,2 Linlin Zhang,2 Diansheng Zhong2 1Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical ...
Jia B, Lv H, Gong T, Wang X, Ma Q, Ren Y, Zhang L, Zhong D   +7 more
doaj  

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Interleukin-6 as a Predictive Marker for Lymph Node and Distant Metastasis in Colorectal Cancer: A Retrospective Cohort Study

Cancer Management and Research
Jianjun Xiao, Muyou Tian, Guoyu Chen, Huifen Li Department of Medical Oncology, Zhongshan City People’s Hospital, Zhongshan, Guangdong, People’s Republic of ChinaCorrespondence: Huifen Li, Department of Medical Oncology, Zhongshan City People’s Hospital,
Xiao J, Tian M, Chen G, Li H
doaj  

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2018
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer address diagnosis, staging, surgical management, perioperative treatment, management of recurrent and metastatic disease, disease surveillance, and survivorship in ...
A. Benson, A. Venook, M. Al-Hawary, L. Cederquist, Yi-Jen Chen, K. Ciombor, S. Cohen, H. Cooper, D. Deming, P. Engstrom, J. Grem, A. Grothey, H. Hochster, S. Hoffe, S. Hunt, A. Kamel, Natalie N. Kirilcuk, S. Krishnamurthi, W. Messersmith, J. Meyerhardt, M. Mulcahy, James D. Murphy, Steven J. Nurkin, L. Saltz, Sunil Sharma, D. Shibata, J. Skibber, C. Sofocleous, E. Stoffel, E. Stotsky-Himelfarb, C. Willett, E. Wuthrick, K. Gregory, Lisa A. Gurski, Deborah A. Freedman-Cass   +34 more
semanticscholar   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Prognostic Impact of Advanced Lung Cancer Inflammation Index (ALI) on Immunotherapy Outcomes in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Post Hoc Analysis

Journal of Inflammation Research
Shihong Xu,1,* Zheran Liu,1,* Ge Song,1,* Yiyan Pei,1 Murong He,2 Junyou Ge,3 Yan Qing,3 Youneng Wei,3 Meiying Shao4 1Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, People’s Republic of ...
Xu S, Liu Z, Song G, Pei Y, He M, Ge J, Qing Y, Wei Y, Shao M   +8 more
doaj  

The association of human immunodeficiency virus and skeletal metastases in breast cancer using Tc-99m methyl diphosphonate bone scan

World Journal of Nuclear Medicine, 2018
Skeletal involvement occurs in 30%–70% of all cancer patients, with breast cancer (BC) being the leading cause for bone metastases in women and prostate cancer in men followed by lung cancer.
Masha Maharaj, Nisaar Korowlay
doaj   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source